ARCH Venture Management, LLC
Source: SEC Form 13F · as of Mar 2026ARCH Venture Management, LLC holds 3 biotech & pharma companies tracked by BioSniper, totaling $296.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
3
Total value held
$296.3M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Maze Therapeutics, Inc. (MAZE)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| MAZEMaze Therapeutics, Inc. | 4,120,053 | $123.0M |
| BEAMBeam Therapeutics Inc. | 4,540,132 | $108.2M |
| LYELLyell Immunopharma, Inc. | 3,247,162 | $65.1M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.